HHS Earmarks Nearly $25M For Research Into Psychedelics As Mental Health Treatment

HHS Earmarks Nearly $25M For Research Into Psychedelics As Mental Health Treatment The Advanced Research Projects Agency for Health and the National Institute of Mental Health will invest millions for research into ibogaine, ketamine, esketamine, and psilocybin as treatments for mental health disorders, including PTSD, as well as for substance use disorders. https://kffhealthnews.org/morning-breakout/mental-health-111326/